# JuneBrain Inc.

> JuneBrain Inc. is a Baltimore medtech startup building a wearable, AI-powered eye-scanning system that brings optical coherence tomography (OCT) out of the eye clinic and into neurology, primary care, and the home. Its flagship Neuro-i SS-OCT captures high-resolution retinal images without a technician, and its AI software turns those images into quantitative biomarkers clinicians can use to monitor diseases like multiple sclerosis, Alzheimer's, and Parkinson's between visits. Founded in 2017 by neuroscientist Samantha Scott after her own diagnosis with a neuromuscular disorder, the company is a WBENC-certified women-owned business on track for FDA submission in 2026.

- **Founded:** 2017
- **Headquarters:** Baltimore, Maryland, United States
- **Founders:** Samantha Scott, PhD (Founder & CEO)
- **Team size:** ~15 employees
- **Products:** Neuro-i SS-OCT, Reading Center / AI Software Platform
- **Notable:** Founded 2017 by neuroscientist Samantha Scott, PhD, Awarded ~$1M National Science Foundation grant (plus additional NSF SBIR/STTR Phase I & II awards totaling ~$3M in grants), Four issued patents

## Products & services

- **Neuro-i SS-OCT** — A wearable, non-invasive, AI-powered swept-source optical coherence tomography device that captures high-resolution retinal images without a technician, designed to monitor eye and brain disease at the point of care and remotely.
- **Reading Center / AI Software Platform** — AI SaaS software that performs automated multi-layer retinal segmentation and analysis, converting scans into quantitative biomarkers clinicians and researchers can use to track disease progression and treatment response.

## Achievements

- Founded 2017 by neuroscientist Samantha Scott, PhD
- Awarded ~$1M National Science Foundation grant (plus additional NSF SBIR/STTR Phase I & II awards totaling ~$3M in grants)
- Four issued patents
- Built and tested working Neuro-i SS-OCT prototypes
- Enrolled nearly 100 patients across three company-sponsored clinical studies
- Winner, New Orleans BioInnovation Center BioChallenge 2025
- Secured ETC Baltimore co-investment in 2026 Series Seed+ round
- WBENC-certified women-owned small business
- On track for FDA submission in 2026 with a reported $6M qualified sales pipeline

## Latest updates

- **2026-02** — ETC Baltimore announced a $200K co-investment in JuneBrain's Series Seed+ round, accelerating its path toward FDA clearance and early commercial launch.
- **2025** — Named a winner of the New Orleans BioInnovation Center BioChallenge 2025; received joint investment from New Orleans BioFund and Gulf South Angels.
- **2026** — On track for FDA submission with four issued patents and a reported $6M qualified sales pipeline.

## Links

- Website: https://junebrain.com
- LinkedIn: http://www.linkedin.com/company/junebrain
- Twitter/X: https://twitter.com/JuneBrainInc
- Instagram: https://www.instagram.com/junebraininc/
- Facebook: https://www.facebook.com/people/JuneBrain-Inc/100075825236539/

---

Profile page: https://yespress.io/junebrain-inc
Published by YesPress — https://yespress.io
Last updated: 2026-08-04